Trailing-twelve-month (TTM) revenue is $122.84 Million with a year-over-year growth of (20.89%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $30,464,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $32,338,033 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-27 |
| Q1 FY2026Period ended 2026-03-31 | $27,924,756 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $32,113,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $122,839,789 |
Current P/S: $537,752,587 market capitalization ÷ $122,839,789 TTM revenue = 4.38x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:35:14.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $32.11M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:35:51.831Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Other Member | $550,260 | N/A |
| Other Revenue Member | N/A | $1M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| CANADA | $9M |
| ICELAND | $69M |
| Non-US | $1M |
| SINGAPORE | $7M |
| UNITED STATES | $27M |
$122.84M
$122.84 Million
(20.89%)
vs. $155.28M a year ago (TTM)
+5.80%
5 Year compound annual growth rate
1 Year
(20.89%)
3 Year
+53.11%
5 Year
+5.80%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $113.56M | ($50.20M) | (30.65%) |
| 2024 | $163.76M | +$118.84M | +264.59% |
| 2023 | $44.92M | +$12.62M | +39.07% |
| 2022 | $32.30M | ($63.78M) | (66.39%) |
| 2021 | $96.08M | +$75.01M | +356.10% |
| 2020 |
TTM Growth
(20.89%)
3-Year CAGR
+53.11%
5-Year CAGR
+5.80%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $21.07M |
| +$13.18M |
| +167.01% |
| 2018 | $7.89M | +$935,201 | +13.45% |
| 2017 | $6.95M | +$3.25M | +87.65% |
